This blog explains why virtual pharmaceutical companies need stronger CMO oversight when transitioning from clinical trials to commercial manufacturing. It highlights the importance of inventory visibility, regulatory compliance, production tracking, and better coordination with contract manufacturers. Visit - https://www.slingshotpharma.com/blog/virtual-pharma-cmo-oversight-commercial-manufacturing
54 Views